Swiss drug authority Swissmedic has begun evaluating the so-called “Covid-19 Vaccine AstraZeneca”. It is the first time that a drugmaker has presented a coronavirus vaccine for approval in Switzerland.
AstraZeneca, which developed the vaccine in collaboration with the University of Oxford, submitted its application to Swissmedic at the start of this month.
The vaccine’s scientific evaluation will be done via a “rolling submission” process. This allows a pharmaceutical company to launch the application procedure before a product’s development is complete.
This “enables Swissmedic to carry out the scientific assessment of non-clinical data from laboratory tests while clinical trials are still in progress,” announced Swissmedic in a statement on Tuesday, noting that trial results must be submitted for scientific review as they become available over the next weeks and months.
More
More
Half of Swiss would get vaccinated against Covid-19
This content was published on
If there were an efficient vaccination against coronavirus, every second person in Switzerland would take it, says a survey.
“However, no decision on authorisation can be taken until all the data needed to assess the safety, quality and efficacy of the vaccine have been submitted. The documentation must demonstrate how safe and effective the vaccine is in protecting humans against the new SARS-CoV-2 coronavirus,” wrote the Swiss drug authority.
Swissmedic noted that while it is reviewing the vaccine independently, it is also working closely with partner authorities abroad. No medicinal product can go onto the Swiss market without Swissmedic’s approval.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
At least four deaths in Swiss Alps over Pentecost weekend
This content was published on
Three of the fatalities over the long weekend were the result of avalanches, while one ski tourer fell to his death, authorities have reported.
Pro-Palestine uni protests to be debated in Swiss parliament
This content was published on
The Swiss People’s Party says it will launch two postulates calling for clarifications about the recent student protests and occupations.
This content was published on
A 36-year-old man from Ticino lost his life on Saturday in Val Malvaglia, in the north of canton Ticino, during a wingsuit jump from a plane.
Swiss Evangelical Reformed Church numbers dropping in French-speaking Switzerland
This content was published on
As in German-speaking Switzerland, the number of members of the Reformed Church in French-speaking Switzerland is also declining.
Gotthard traffic queue hits 20km during holiday weekend
This content was published on
The traffic jam at the Gotthard north portal reached a length of 20 kilometres on the motorway between canton Nidwalden and canton Uri.
Swiss Interior Minister visits Cannes Film Festival
This content was published on
Swiss Interior Minister left the Cannes Film Festival on Saturday after three days of intensive dialogue, meetings and film screenings.
Swiss theatre director breaks with tradition at Vienna’s Rathausplatz
This content was published on
With the proclamation of the "Free Republic of Vienna", the start of the festival on Friday evening was unusually political.
Switzerland pre-orders 4.5 million doses of Covid-19 vaccine
This content was published on
The Swiss government has signed a deal with US biotech firm Moderna to secure early access to 4.5 million doses of a Covid-19 vaccine currently in development.
Switzerland fast-tracks antiviral medication against Covid-19
This content was published on
Swissmedic, the agency that oversees the use of medicaments in Switzerland, took days to fast-track approval of the drug, which is produced under the brand name Veklury by US biopharmaceutical company Gilead Sciences. The application for its extended use was only received on Monday. It can now be used for a limited period of time to…
Join the conversation!